CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026
Go back to CytomX Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.45 +0.01 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.44 | 52 Week High | $24.68 | |||
| Open | $3.42 | 52 Week Low | $9.10 | |||
| Day High | $3.50 | P/E | N/A | |||
| Day Low | $3.37 | EPS | $0.00 | |||
| Volume | 1,698,607 | |||||
